Sustainability & Climate

858 Therapeutics' novel PARG inhibitor offers new hope for patients with a deadly, drug-resistant form of ovarian cancer, accelerating its path to approval.

Echo Water's new Echo One promises ultra-pure, hydrogen-rich water on demand. But is the cutting-edge science and technology worth the premium price tag?

The opioid treatment specialist projects over $1.1B in revenue, driven by its flagship drug SUBLOCADE and a major strategic overhaul in the U.S.

Otis secures a major TfL contract to upgrade 172 escalators, blending a century of history with future-ready tech for a smarter, more reliable commute.

Rani Therapeutics starts Phase 1 trials for an oral obesity drug, challenging the injectable market with a novel delivery system and a dual-action compound.

Everest Group recognizes CGI's role in India's booming GCC market, where hubs for digital transformation and AI now balance innovation with efficiency.

With over 30 years of experience, Leonard Carder takes the helm at 4M Building Solutions, signaling a new chapter of aggressive acquisition and innovation.

The software giant is launching AI-powered AP automation, mobile payments, and integrated financing to tackle contractor cash flow and operational headaches.

As the eVTOL race intensifies, Vertical Aerospace appoints key execs from Lotus, Nike, and AB InBev to spearhead its push for certification and scale.

Pharma giant Bayer partners with biotech innovator Soufflé to develop a groundbreaking siRNA therapy, aiming to deliver genetic medicine directly to the heart.

At CES 2026, LumiMind's BCI tech promises to guide you to sleep and power thought-controlled games, raising major scientific and ethical questions.

Azafaros presents its promising drug, nizubaglustat, for untreatable rare neurological disorders, backed by major funding and late-stage clinical trials.

Biotech leader Arrowhead Pharmaceuticals prices upsized offerings, signaling strong investor confidence and fueling its next wave of RNAi therapies.

The Michigan-based firm moves beyond asset disposal, launching end-to-end services to help organizations cut costs, boost efficiency, and secure data.

As the fitness market booms, TaiSPO 2026 in Taipei unveils the future with smart tech, holistic wellness zones, and a new startup innovation hub.

Rebranded and recapitalized, Future Mineral Resources is raising $4.5M to advance its gold, uranium, and nickel projects across three continents.

With its $20M IPO, Buda Juice plans a national expansion. Its goal: make its cold-crafted, clean-label juices the new standard for fresh beverages.

Dexcel Pharma USA acquires Zubsolv®, a key opioid addiction therapy, signaling a major strategic shift into the branded drug market in the U.S.

Sana Biotechnology prepares for its pivotal J.P. Morgan update, balancing groundbreaking diabetes data against a ticking financial clock and fierce competition.

A year after LA's devastating fires, experts reveal how common plastics in homes create toxic infernos that poison communities long after the flames die out.